Pricing Log in Create free account
Saturday 17 October 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Labcorp Holdings Inc. (LH) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a EV/EBITDA of 14.5×. Over the past ten years it has ranged from 5.1× (July 2021) to 18.3× (January 2024); the current reading is higher than 81% of that period. That is below the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.3× (7.69%)
FY2024 13.4× (26.99%)
FY2023 18.3× 54.34%
FY2022 11.9× 42.73%
FY2021 8.3× 34.83%
FY2020 6.2× (42.37%)
FY2019 10.7× 20.76%
FY2018 8.9× (19.81%)
FY2017 11.0× 20.54%
FY2016 9.2× (15.09%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.1× 3.42%
Mar 2026 12.6× 2.39%
Dec 2025 12.3× (12.59%)
Sep 2025 14.1× (0.50%)
42 more quarters

Against its own ten years

Low 5.1× High 18.3×
Ten-year median 11.2×
Current reading's percentile 81

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. 14.5×
RVTY Revvity Inc. compare 24.8×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
MEDP Medpace Holdings, Inc. compare 27.9×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LH